Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 55 | 56 | +1 |
| Shares | 6.96M | 7.67M | +706.5K (+10.2%) |
| Value | $17.0M | $18.6M | +$1.57M (+9.2%) |
New holders (9)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Peapod Lane Capital LLC | 227,239 | $549.9K | 0.55% |
| Marquette Asset Management, LLC | 33,311 | $80.6K | 0.01% |
| World Equity Group, Inc. | 20,000 | $48.4K | 0.01% |
| Simplex Trading, LLC | 3,857 | $9.00K | 0.00% |
| National Bank of Canada | 2,500 | $6.05K | 0.00% |
| SBI Securities Co., Ltd. | 1,640 | $3.97K | 0.00% |
| Golden State Wealth Management, LLC | 303 | $733 | 0.00% |
| Hopwood Financial Services, Inc. | 200 | $484 | 0.00% |
| Atala Financial Inc | 100 | $242 | 0.00% |
Sold out (8)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| XTX Topco Ltd | 24,716 | $60.3K |
| Marshall Wace, LLP | 22,527 | $55.0K |
| Savvy Advisors, Inc. | 18,810 | $45.9K |
| Assenagon Asset Management S.A. | 13,118 | $32.0K |
| Virtu Financial LLC | 12,123 | $30.0K |
| Mariner, LLC | 10,544 | $25.7K |
| City Holding Co | 1,070 | $2.61K |
| Nordwand Advisors, LLC | 1,000 | $2.44K |